Pancreatic adenocarcinoma is the fourth leading cause of cancer death in the United States. It is identified by its rapid, invasive progression with a profound resistance to treatments such as chemotherapy. Unfortunately, there is a lack of information on how to effectively inhibit and control the rapid growth of pancreatic tumors, as well as limited information for diagnostics. With current
methods, pancreatic cancer will continue to prevail as a leading cause of cancer death. We propose to study the complexity of pancreatic tumors with a systematic and analytical approach. Cancer is an abnormal growth of tissue caused by uncontrolled cell division. Observing the growth of these cells would prove to have a good basis to monitor the growth of a tumor. Here we create a 3-D simulation of tumor growth through mathematical modeling, using data from pancreatic cells grown in vitro. Using 3-D models will help to understand pancreatic tumors at cellular and molecular levels.
The project aims to observe realistic growth of the tumor, accomplished from growing tumor cells on a monolayer in order to find parameters for our 3D mathematical model. This method will prove more beneficial than testing only on a monolayer cell line. Although cell death and the toxicity of drug dosage can be tested using a cell monolayer alone, it does not meet the demands of testing drug delivery in a realistic tumor environment that the mathematical model would provide. The monolayer lacks the dimensions that the drug would have to travel if it were delivered to a real in vivo tumor. A possible continuation of this project in the future could be to utilize the mathematical based approach to predict optimal therapy for the pancreatic tumor in order to develop models that can better test patient care for tumors. Computer modeling, another stepping stone through mathematical modeling, will possibly lead to testing the toxic effects of drugs on a 3-D model through computer modeling will aid in understanding the delivery of drugs throughout the tumor in vivo. 
NOMENCLATURE

I. Introduction
Pancreatic adenocarcinoma is the fourth leading cause of cancer death in the United States. Out of the population in the U.S., it was estimated that 37,000 men and women will die from pancreatic cancer in 2012 alone (statistics from National Cancer Institute). Even when the tumor was identified, there was only a 5% chance of survival [3] . This may lend to the fact that diagnostics fail to locate a pancreatic growth until it has grown sufficiently into a malignant tumor. A pancreatic tumor is identified by its rapid, invasive progression with a profound resistance to treatments such as chemotherapy. It goes unnoticed for months without notice due to its deep location, hidden by other organs. It may only present itself when it grows large enough and begins to push against surrounding tissue, such as intestine, bile ducts, and nervous system [7] . Even then, the initial diagnosis can be associated with other illnesses due to the tumor only presenting unspecific symptoms (i.e. nausea, difficult motor function). This leaves patients with a late stage of correct diagnosis and a smaller survival rate.
A problem, therefore, seems to be poor understanding of what occurs when a tumor becomes malignant. Diagnostics aimed specifically at pancreatic cancer have not advanced much. With the rapid growth of pancreatic cancer, diagnosticians need to know what stage a tumor has entered in order to quickly assess the proper treatment a patient requires. To this end, a link between tumor stages and the rapid growth of pancreatic cancer would assist in finding the best course of action for a patient after diagnosis of the tumor.
The proposed project is to use mathematical models to represent tumor growth. Unlike observing growth of cancer through monolayers, this model would allow us to understand the more complex arrangement of tumor cells as they interact [1] , [2] . This is a relatively new method for observing cancer growth. This provides a better way of studying cellular interactions and would represent an in vivo environment. It is believed that this will provide a guideline to identify when a tumor mass is benign or malignant [5] .
II. Materials and Methods
A. Summary
The mathematical model for the tumor will represent a tumor mass that grows in an avascular spheroid. Like cells growing on a monolayer, the avascular spheroid will only grow from oxygen and nutrients (from growth factors of the cell media) through diffusion instead of a blood supply. For a tumor spheroid, cells interact by adhering to each other and continue its growth. The outer cells of the spheroid will proliferate while the interior cells die to form a necrotic core due to a lack of nutrients. The distance oxygen and nutrients will usually travel is approximately 100µm before being absorbed by cells, limiting the size of an avascular tumor.
For the mathematical models, the tumors are limited to 500µm to 2000µm [20] .
Multicellular spheroid models are developed in vitro to observe its interaction with the environment and the cell-cell interaction of the spheroid [7] , [8] , [9] , [10] , [11] , [12] . Although it's usually vascular tumors that demonstrate irregular shapes, avascular spheroids begin to show different morphologies as well [4] .
Metastasis can be monitored using mathematical models to observe when tumors begin to bud and branch out from a typical avascular spheroid shape [5] .
Early continuum models [13] , [14] were developed for tumor growth for the diffusion of nutrients. Other studies take into account conditions of a tumor for in vivo, such as immune response [15] , mitotic inhibitor [15] , [38] , apoptosis [16] , and growth stability [17] . 
D. Mathematical Model Setup
Following the design of a continuum model [18] , it's assumed that the cell density of the proliferating cells is constant. Therefore, mass changes correspond to volume changes. Defining u to be the cell velocity, volume change is:
where λ p is the cell-proliferation rate, defined by:
where n denotes the concentration of a cell substrate (e.g. oxygen or glucose). λ p corresponds to proliferation through mitosis while λ A is the rate of volume loss due to apoptosis (programmed cell death). Here, λ A is the rate of apoptosis and b is a measure of mitosis.
Since the rate of diffusion of oxygen and nutrients is much faster (e.g. ∼1 min −1 )
than the rate of cell proliferation (e.g. ∼1 day −1 ), the substrate may be regarded to be in a steady state for a given tumor morphology (e.g. [21, 18, 22, 14] ). This gives:
where is the rate at which nutrient is added to the tumor, described by:
Here, λ B is the blood-tissue transfer rate of nutrient, n B is the concentration of nutrient in the blood and λ is the rate of consumption of nutrient by the tumor cells. λn describes nutrient uptake by the tumor cells. It is subtracted from the source of nutrient of the vasculature to give the rate of nutrient given. In this simplified model, the vasculature is assumed to be uniform, and vascular growth is associated with a bulk source of oxygen and nutrients. Growth is limited by the diffusion of the cell substrates according to this model.
To determine the cell velocity, Darcy's law may be used as the constitutive assumption [21] , [18] , [22] , [13] :
where P is the oncotic (solid) pressure and µ is a mobility that reflects the combined effects of cell-cell and cell-matrix adhesion. Alternatively, the velocity may be determined using the Stokes equations [ 
(P ) = γ κ (7) where the pressure boundary condition (7) reflects the influence of cell-cell adhesion through the parameter γ and κ. Together, these two terms make the local total curvature. For equation (6), assume n ∞ is constant so that outside the tumor, the nutrient is uniform. Nutrient inhomogeneity in the tumor microenvironment in The normal velocity of the tumor boundary [21] , [18] , [22] , [13] is:
Following [21] , [18] , [22] , [13] and others, assume that λ, λ A , λ B , n B , and b are uniform. Following [18] , denote λ M = bn ∞ (9) to be the characteristic mitosis rate, 
where G and A [18] measure the relative strength of cell-cell and cell-matrix adhesion and apoptosis, respectively:
Boundary equations for and p can be obtained:
(p) = κ − AG(x 2 )/2d (17) in a d-dimensional tumor (d = 2, 3). The non-dimensional normal velocity of the tumor [18] is:
A study of spherically symmetric tumor growth provides insight into the regimes of growth described by the model [21] , [18] .
For a radially symmetric tumor, |G| rescales time. In all dimensions, unbounded growth (R → ∞) occurs if and only if AG is much greater than 0. Three regimes of growth are identified [18] , and the behavior is qualitatively unaffected by the number of dimensions d.
(1) Low vascularization: G is much greater than 0 and A greater than 0 (B < ).
Note that the special case of avascular growth (B = 0) belongs to this regime. The evolution always leads to a stationary state R ∞ (if A > 1, then R ∞ = 0). This behavior is in agreement with experimental observations of in vitro diffusional growth [14] of avascular spheroids to a dormant steady state [9] , [10] . In the experiments, however, tumors always develop a necrotic core that further stabilizes their growth [37].
(2) Moderate vascularization: G is much greater than 0 and A is greater than 0, where 1 > B (which is much greater than ). Unbounded growth occurs from any initial radius R 0 > 0. The growth tends to be exponential for A < 0 with velocity V approaching ), as R approaches ∞, and to be linear for A = 0 with velocity V approaching G as R approaches ∞.
(3) High vascularization: G < 0 (where B > 1). For A > 0, growth (V > 0) may occur, depending on the initial radius, and is always unbounded; for A < 0 (for which cell apoptosis is dominant: > B), the evolution is always to the only stationary solution R ∞ = 0. This stationary solution may also be achieved for A > 0. The stationary radius R ∞ is independent of G, and is a solution of V = 0 with V from equation (19) .
Mass growth of a spheroid tumor can be monitored by observing the expansion of its radius over a period of time. The growth and shape of spheroids grown in vitro were governed by specific variables [1] : diffusion length L, the ratio of cell death rate to cell mitosis rate A, and the ratio of cell mitosis rate to relaxation rate G.
The evolving growth of a spheroid [1] can be represented as:
Where R is the radius of a tumor, and A is the cell death to cell proliferation ratio.
The ratio for A can be shown as:
As a tumor cell continues to grow, it growth begins to plateau until its radius becomes near constant when it doesn't have a vascular source. Its growth was only governed by the nutrients and oxygen that can diffuse through the tumor of length L [2] . From Equation 1, and setting the change of R as zero at steady state [2] , the new equation is:
The radius of avascular tumors usually span a radius of 500µm to 2000µm. Using these parameters, the death rate to mitosis rate A can be estimated.
III. Data and Results
A chart was made using the number of cells for 24hr, 48hr, 60hr, and 72hr times. From the initial slope from the chart of cancer cell growth, shown in Figure 1 , the mitosis rate (λ M ) can be calculated. From the chart, λ M was approximately 3638.4.
The cell death rate can thus be calculated by knowing A.
The radius of avascular tumors usually span a radius of 500µm to 2000µm. Using these parameters, the death rate to mitosis rate A can be estimated, as seen in 
IV. Discussion
From Figure 3 , the stability of the tumor mass is monitored. Following the stationary curve in the center, any tumor in the shaded area and to the left is morphologically stable. As the radius increases along the stationary curve (when = 0), moving past the shaded area to the right, the tumor becomes unstable. The increase of the radius as its growth plateaus is an indication that the tumor is developing a small G ratio and a larger relaxation rate. This instability was based on the spheroid shape of the tumor. As instability increases, the cell adhesion forces that keep the tumor together deteriorate and the tumor begins to bud and expand. Budding parts of the tumor mark the invasiveness of a tumor, increasing the surface area of the tumor for more nutrients and oxygen. Morphological instability is an indicator of metastasis, and observing parameters through mathematical models allow practitioners to monitor tumor activity.
Metastasis was previously thought to derive from malignant tumors [6] , but newer reconsiderations are being tested for a tumor's metastatic ability. Models that demonstrate branching represent in vivo tumors that are invading surrounding tissue. The important concept to take away from this is that branching areas of tumor cells have the potential to absorb more nutrients and oxygen, and could eventually "pinch off" of the original tumor.
The aim of these mathematical models and cells grown in vitro is to represent in vivo tumor growth. Understanding growth of 3D tumors will benefit diagnosticians to make decisions on the best course of treatment for each patient.
In the future, mathematical models can aid research to counter tumor progression.
Pancreatic cancer is a particularly aggressive cell line that can be monitored morphologically to understand and limit its invasive nature. The aggressive nature of pancreatic cancer leads to a high mortality rate in patients. Understanding the tumor growth of these cells would not only act as a beneficial model in designing drug deliveries and therapies, but alert diagnosticians when a tumor is approaching malignant condition. With this goal, mathematical models can be designed to predict the 3D nature of cancerous tumors, as well as its growth and progression toward metastasis.
